TABLE 2.

MACE and malignancy outcomes.

	MACE cohort (N = 16 012)	Malignancy cohort (N = 14 545)
Total number of outcome events, n	214	315
Total length of follow‐up, years	43 964.70	40 251.60
IR per 100 PY	0.49	0.78
Stroke events a , n	150	—
Total length of follow‐up, years	44 011.24	—
IR per 100 PY	0.34	—
MI events a , n	35	—
Total length of follow‐up, years	44 134.26	—
IR per 100 PY	0.08	—
Heart failure events a , n	27	—
Total length of follow‐up, years	44 180.63	—
IR per 100 PY	0.06	—
Other ischemic heart disease events a , n	2	—
Total length of follow‐up, years	44 180.71	—
IR per 100 PY	< 0.01	—

Abbreviations: IR, incidence rate; MACE, major adverse cardiovascular events; MI, myocardial infarction; N, total number of eligible patients; n, number of events; PY, patient‐years.

^a MACE cohort only.